Tuder RM - Search Results

1

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF. Geraci MW, et al. Among authors: tuder rm. J Clin Invest. 1999 Jun;103(11):1509-15. doi: 10.1172/JCI5911. J Clin Invest. 1999. PMID: 10359560 Free PMC article.

2

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Tuder RM, Groves B, Badesch DB, Voelkel NF. Tuder RM, et al. Am J Pathol. 1994 Feb;144(2):275-85. Am J Pathol. 1994. PMID: 7508683 Free PMC article.

3

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.

Tuder RM, Flook BE, Voelkel NF. Tuder RM, et al. J Clin Invest. 1995 Apr;95(4):1798-807. doi: 10.1172/JCI117858. J Clin Invest. 1995. PMID: 7706486 Free PMC article.

4

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.

Voelkel NF, Tuder RM, Bridges J, Arend WP. Voelkel NF, et al. Among authors: tuder rm. Am J Respir Cell Mol Biol. 1994 Dec;11(6):664-75. doi: 10.1165/ajrcmb.11.6.7946395. Am J Respir Cell Mol Biol. 1994. PMID: 7946395

5

Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.

Voelkel NF, Tuder R. Voelkel NF, et al. Ann N Y Acad Sci. 1994 May 28;725:104-9. doi: 10.1111/j.1749-6632.1994.tb39794.x. Ann N Y Acad Sci. 1994. PMID: 8030981 No abstract available.

6

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Voelkel NF, Tuder RM, Wade K, Höper M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F. Voelkel NF, et al. Among authors: tuder rm. J Clin Invest. 1996 Jun 1;97(11):2491-8. doi: 10.1172/JCI118696. J Clin Invest. 1996. PMID: 8647941 Free PMC article.

7

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.

Voelkel NF, Tuder RM. Voelkel NF, et al. Among authors: tuder rm. Eur Respir J. 1995 Dec;8(12):2129-38. doi: 10.1183/09031936.95.08122129. Eur Respir J. 1995. PMID: 8666110 Free article. Review.

8

Vascular endothelial growth factor in pulmonary hypertension.

Voelkel NF, Hoeper M, Maloney J, Tuder RM. Voelkel NF, et al. Among authors: tuder rm. Ann N Y Acad Sci. 1996 Oct 31;796:186-93. doi: 10.1111/j.1749-6632.1996.tb32580.x. Ann N Y Acad Sci. 1996. PMID: 8906225

9

Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.

Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH. Ivy DD, et al. Among authors: tuder rm. J Clin Invest. 1997 Mar 15;99(6):1179-86. doi: 10.1172/JCI119274. J Clin Invest. 1997. PMID: 9077525 Free PMC article.

10

Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection.

Cool CD, Kennedy D, Voelkel NF, Tuder RM. Cool CD, et al. Among authors: tuder rm. Hum Pathol. 1997 Apr;28(4):434-42. doi: 10.1016/s0046-8177(97)90032-0. Hum Pathol. 1997. PMID: 9104943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters